ENvue Medical Secures USPTO Notice of Allowance for Cannabinoid Drug Delivery Technology

ENvue Medical, Inc. has received a Notice of Allowance from the USPTO for its patent application concerning a drug delivery system that uses proprietary surface acoustic wave (SAW) technology to enhance the transdermal delivery of cannabinoid-based therapeutics. This development indicates a significant expansion of ENvue’s SAW platform into new therapeutic areas, reflecting the potential for improved therapeutic administration and strategic collaborations in the cannabinoid sector.